Effect of meditation on neurophysiological changes in stress mediated depression

Complementary Therapies in Clinical Practice

Volumn 20, Issue 1, 2014, Pages 74-80

  Kasala, Eshvendar Reddy ^a   Bodduluru, Lakshmi Narendra ^a   Maneti, Yogeshwar ^a   Thipparaboina, Rajesh ^b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Cytokines; Depression; Meditation; Stress and neurophysiology

Indexed keywords

CYTOKINE;

DEPRESSION; HUMAN; MEDITATION; MENTAL STRESS; PATHOPHYSIOLOGY; REVIEW; STRESS AND NEUROPHYSIOLOGY;

CYTOKINES; DEPRESSION; MEDITATION; STRESS AND NEUROPHYSIOLOGY;

DEPRESSION; HUMANS; MEDITATION; STRESS, PSYCHOLOGICAL;

EID: 84892553172     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2013.10.001     Document Type: Review

References (80)

1. Schechter L.E., Ring R.H., Beyer C.E., Hughes Z.A., Khawaja X., Malberg J.E., et al. Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2005, 2:590-611.
2. Mathers C., Fat D.M., Boerma J.T. The global burden of disease: 2004 update 2008, World Health Organization.
3. Spitzer R.L., Gibbon M.E., Skodol A.E., Williams J.B.W., First M.B. DSM-IV casebook: a learning companion to the diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association. 4th ed.
4. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157:1552-1562.
5. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
6. Peng Y.L., Wang W.Y., Jiang C.L., Wang Y.X. Roles of cytokines in stress-induced depression. Sheng Li Xue Bao 2013, 65:229-236.
7. Bouvier N., Trenque T., Millart H. Development of antidepressant drugs. Experience and prospects. Presse Med 2003, 32:519.
8. Shen J., Liang Z. Advances in research on biological etiology of depression and the antidepressants. Pharma Care Res 2007, 7:94.
9. Jensen P.S., Arnold L.E., Swanson J.M., Vitiello B., Abikoff H.B., Greenhill L.L., et al. 3-year follow-up of the NIMH MTA study. JAm Acad Child Adolesc Psychiatry 2007, 46:989-1002.
10. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 2008, 5:e45.
11. NCCAM Mind-body medicine: an overview 2005.
12. Young J.D.-E., Taylor E. Meditation as a voluntary hypometabolic state of biological estivation. News Physiol Sci 2001, 13:149-153.
13. Jevning R., Wallace R.K., Beidebach M. The physiology of meditation: a review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev 1992, 16:415-424.
14. Marchand W.R. Mindfulness meditation practices as adjunctive treatments for psychiatric disorders. The Psychiatr Clin North Am 2013, 36:141-152.
15. Rubia K. The neurobiology of meditation and its clinical effectiveness in psychiatric disorders. Biol Psychol 2009, 82:1-11.
16. da Silva T.L., Ravindran L.N., Ravindran A.V. Yoga in the treatment of mood and anxiety disorders: a review. Asian J Psychiatr 2009, 2:6-16.
17. Ospina M.B., Bond K., Karkhaneh M., Tjosvold L., Vandermeer B., Liang Y., et al. Meditation practices for health state of the research. Evid Rep Technol Assess 2007, 155:1-263.
18. Tang Y.Y., Ma Y., Wang J., Fan Y., Feng S., Lu Q., et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci 2007, 104:17152-17156.
19. Davidson R.J., Kabat-Zinn J., Schumacher J., Rosenkranz M., Muller D., Santorelli S.F., et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003, 65:564-570.
20. Kendler K.S., Thornton L.M., Gardner C.O. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry 2000, 157:1243-1251.
21. Johnson E.O., Kamilaris T.C., Chrousos G.P., Gold P.W. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev 1992, 16:115-130.
22. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
23. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991, 43:425-473.
24. King S.L., Hegadoren K.M. Stress hormones: how do they measure up?. Biol Res Nurs 2002, 4:92-103.
25. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000, 21:55-89.
26. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008, 31:464-468.
27. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:722-729.
28. Johnson J.D., Campisi J., Sharkey C.M., Kennedy S.L., Nickerson M., Greenwood B.N., et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005, 135:1295-1307.
29. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., et al. Amechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci 2003, 100:1920-1925.
30. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19:493-499.
31. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998, 105:83-107.
32. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
33. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002, 53:545-574.
34. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001, 11:240-249.
35. Yang T.T., Simmons A.N., Matthews S.C., Tapert S.F., Frank G.K., Max J.E., et al. Adolescents with major depression demonstrate increased amygdala activation. JAm Acad Child Adolesc Psychiatry 2010, 49:42-51.
36. Murray E.A., Wise S.P., Drevets W.C. Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala. Biol Psychiatry 2011, 69:e43-e54.
37. Naismith S.L., Norrie L.M., Mowszowski L., Hickie I.B. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol 2012, 98:99-143.
38. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 2002, 51:68-80.
39. Holtzheimer P.E., Mayberg H.S. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci 2011, 34:1-9.
40. McKinnon M.C., Yucel K., Nazarov A., MacQueen G.M. Ameta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. JPsychiatry Neurosci 2009, 34:41-54.
41. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004, 161:598-607.
42. Bench C.J., Frackowiak R.S., Dolan R.J. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995, 25:247-261.
43. O'Toole S.M., Johnson D.A. Psychobiology and psychopharmacotherapy of unipolar major depression: a review. Arch Psychiatr Nurs 1997, 11:304-313.
44. Hill M.N., Hellemans K.G., Verma P., Gorzalka B.B., Weinberg J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012, 36:2085-2117.
45. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40:288-295.
46. Walton K.G., Pugh N.D., Gelderloos P., Macrae P. Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. JAltern Complement Med 1995, 1:263-283.
47. Solberg E.E., Holen A., Ekeberg Ø., Østerud B., Halvorsen R., Sandvik L. The effects of long meditation on plasma melatonin and blood serotonin. Med Sci Monit 2004, 10:CR96-101.
48. Infante J.R., Torres-Avisbal M., Pinel P., Vallejo J.A., Peran F., Gonzalez F., et al. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav 2001, 72:141-146.
49. Dunn A.J., Swiergiel A.H. The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems. Eur J Pharmacol 2008, 583:186-193.
50. Lang R., Dehof K., Meurer K.A., Kaufmann W. Sympathetic activity and transcendental meditation. JNeural Transm 1979, 44:117-135.
51. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
52. Streeter C.C., Jensen J.E., Perlmutter R.M., Cabral H.J., Tian H., Terhune D.B., et al. Yoga Asana sessions increase brain GABA levels: a pilot study. JAltern Complement Med 2007, 13:419-426.
53. Robinson F.P., Mathews H.L., Witek-Janusek L. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasi experimental study. JAltern Complement Med 2003, 9:683-694.
54. Kjaer T.W., Bertelsen C., Piccini P., Brooks D., Alving J., Lou H.C. Increased dopamine tone during meditation-induced change of consciousness. Cogn Brain Res 2002, 13:255-259.
55. Jung Y.H., Kang D.H., Jang J.H., Park H.Y., Byun M.S., Kwon S.J., et al. The effects of mind body training on stress reduction, positive affect, and plasma catecholamines. Neurosci Lett 2010, 479:138-142.
56. Fayed N., Lopez Del Hoyo Y., Andres E., Serrano-Blanco A., Bellón J., Aguilar K., et al. Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study. PloS One 2013, 8:e58476.
57. Newberg A.B., Iversen J. The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses 2003, 61:282-291.
58. Kubryak O.V., Umriukhin A.E., Emeljanova I.N., Antipova O.S., Guseva A.L., Pertsov S.S., et al. Increased β-endorphin level in blood plasma as an indicator of positive response to depression treatment. Bull Exp Biol Med 2012, 153:758-760.
59. Maestroni G.J.M. The immunoneuroendocrine role of melatonin. JPineal Res 1993, 14:1-10.
60. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004, 29:448-474.
61. Tooley G.A., Armstrong S.M., Norman T.R., Sali A. Acute increases in night-time plasma melatonin levels following a period of meditation. Biol Psychol 2000, 53:69-78.
62. Lee M.S., Kang C.W., Lim H.J., Lee M.S. Effects of Qi training on anxiety and plasma concentrations of cortisol, ACTH, and aldosterone: a randomized placebo controlled pilot study. Stress Health 2004, 20:243-248.
63. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. JClin Endocrinol Metab 1994, 78:1360-1367.
64. Tang Y.Y., Ma Y., Fan Y., Feng H., Wang J., Feng S., et al. Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci 2009, 106:8865-8870.
65. Brefczynski-Lewis J.A., Lutz A., Schaefer H.S., Levinson D.B., Davidson R.J. Neural correlates of attentional expertise in long-term meditation practitioners. Proc Natl Acad Sci 2007, 104:11483-11488.
66. Cahn B.R., Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull 2006, 132:180.
67. Lazar S.W., Bush G., Gollub R.L., Fricchione G.L., Khalsa G., Benson H. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000, 11:1581-1585.
68. Zope S.A., Zope R.A. Sudarshan kriya yoga: breathing for health. Int J Yoga 2013, 6:4-10.
69. Lazar S.W., Kerr C.E., Wasserman R.H., Gray J.R., Greve D.N., Treadway M.T., et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005, 16:1893-1897.
70. Hölzel B.K., Carmody J., Vangel M., Congleton C., Yerramsetti S.M., Gard T., et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res 2011, 191:36-43.
71. Tang Y.Y., Lu Q., Geng X., Stein E.A., Yang Y., Posner M.I. Short-term meditation induces white matter changes in the anterior cingulate. Proc Natl Acad Sci 2010, 107:15649-15652.
72. Irwin M. Immune correlates of depression. Cytokine Stress Depress 1999, 1-24.
73. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003, 65:571-581.
74. Ross A., Thomas S. The health benefits of yoga and exercise: a review of comparison studies. JAltern Complement Med 2010, 16:3-12.
75. Black D.S., Cole S.W., Irwin M.R., Breen E., St Cyr N.M., Nazarian N., et al. Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroimmunology 2013, 38:348-355.
76. Irwin M.R., Olmstead R., Oxman M.N. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. JAm Geriatr Soc 2007, 55:511-517.
77. Irwin M.R., Olmstead R. Mitigating cellular inflammation in older adults: a randomized controlled trial of Tai Chi Chih. Am J Geriatr Psychiatry 2011, 20:764-772.
78. Jacobs T.L., Epel E.S., Lin J., Blackburn E.H., Wolkowitz O.M., Bridwell D.A., et al. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 2011, 36:664-681.
79. Ryu H., Jun C.D., Lee B.S., Choi B.M., Kim H.M., Chung H.-T. Effect of qigong training on proportions of T lymphocyte subsets in human peripheral blood. Am J Chin Med 1995, 23:27-36.
80. Kochupillai V., Kumar P., Singh D., Aggarwal D., Bhardwaj N., Bhutani M., et al. Effect of rhythmic breathing (Sudarshan Kriya and Pranayam) on immune functions and tobacco addiction. Ann N Y Acad Sci 2005, 1056:242-252.